GENENTECH, INC for GENENTECH INC

Medical/Disease Research/Clinical Labs MED

LHHS Appropriations

Contacted: Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 1145 Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill

Contacted: SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price negotiation Act, medicare noninterference provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, medicare noninterference provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 Comparative Effectiveness

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: S. 3 (110th), H.R. 3162 (110th), S. 2662 (110th), H.R. 5480 (110th), H.R. 4 (110th), S. 2029 (110th)

Budget/Appropriations BUD

House concurrent Resolution 312 FY09 Budget Resolution Senate concurrent Resolution 70 FY09 Budget Resolution Comparative Effectiveness

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Pharmacy PHA

H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price competition and Innovation Act of 207, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.r. 4911, Human Growth Hormone Restriction Act of 2007

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 1956 (110th), S. 1505 (110th), S. 623 (110th), H.R. 5629 (110th), S. 877 (110th), S. 596 (110th), S. 1695 (110th), S. 2029 (110th), H.R. 1038 (110th), H.R. 4911 (110th)